| Description | TG6-129 is an antagonist of the EP2 receptor. TG6-129 suppresses PGE2-induced elevation of cAMP in cells expressing EP2 with an IC50 value of 1.6 µM. TG6-129 reduces the expression of COX-2, IL-1β, IL-6, IL-12, IL-23 and TNF-α induced by the EP2-selective agonist butaprost in P388D1 macrophages. |
| Synonyms | TG6 129 |
| molecular weight | 491.58 |
| Molecular formula | C20H18FN5O3S3 |
| CAS | 1164464-14-5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: 55 mg/mL (111.88 mM) |
| References | 1. Ganesh T, Jiang J, Shashidharamurthy R, Dingledine R. Discovery and characterization of carbamothioylacrylamides as EP(2) selective antagonists. ACS Med Chem Lett. 2013 Jul 11;4(7):616-621. PubMed PMID: 23914286; PubMed Central PMCID: PMC3731160. |